Egfr positive non-small cell lung cancer Clinical Trials
Conditions / Egfr positive non-small cell lung cancer
Delta Trials indexes 18 clinical trials for Egfr positive non-small cell lung cancer in its publicly accessible dataset. Of these, 3 enrolling participants at this time and 3 trials have reached completion. This research takes place spanning 53 research sites around the world. An additional 12 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
18
Total Trials
3
Recruiting
3
Completed
12
Other Active
0
Terminated since 2020
53
Study Locations
Browse by location (53 total)
- Beijing, China 3 trialsAll trials in Beijing, China
- Seoul, South Korea 3 trialsAll trials in Seoul, South Korea
- Nanning, China 2 trialsAll trials in Nanning, China
- Daejeon, South Korea 2 trialsAll trials in Daejeon, South Korea
- Zhengzhou, China 2 trialsAll trials in Zhengzhou, China
- Busan, South Korea 2 trialsAll trials in Busan, South Korea
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Singapore, Singapore 2 trialsAll trials in Singapore, Singapore
- Heidelberg, Germany 1 trialAll trials in Heidelberg, Germany
- Jiangmen, China 1 trialAll trials in Jiangmen, China
- Incheon, South Korea 1 trialAll trials in Incheon, South Korea
- Lanzhou, China 1 trialAll trials in Lanzhou, China
- Munchen, Germany 1 trialAll trials in Munchen, Germany
- Mȕnchen, Germany 1 trialAll trials in Mȕnchen, Germany
- Műnchen, Germany 1 trialAll trials in Műnchen, Germany
- München, Germany 1 trialAll trials in München, Germany
- Changchun, China 1 trialAll trials in Changchun, China
- Anyang-si, South Korea 1 trialAll trials in Anyang-si, South Korea
- Hanzhong, China 1 trialAll trials in Hanzhong, China
- Fairway, United States 1 trialAll trials in Fairway, United States